Does myo‐inositol supplementation influence oxidative stress biomarkers in patients with non‐alcoholic fatty liver disease?
Somayeh Rostami,
Sara Arefhosseini,
Helda Tutunchi
et al.
Abstract:Myo‐inositol (MI) is a carbocyclic sugar polyalcohol. MI has known to exert anti‐inflammatory, anti‐oxidant, and anti‐diabetic activities. This study aimed to investigate the effects of MI supplementation on oxidative stress biomarkers in obese patients with non‐alcoholic fatty liver disease (NAFLD). In this double‐blinded placebo‐controlled randomized clinical trial, 51 newly diagnosed obese patients with NAFLD were randomly assigned to receive either MI (4 g/day) or placebo supplements accompanied by dietary… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.